Diantha Duvall
Director of Finance/CFO bei CURIS, INC.
Vermögen: 7 000 $ am 31.03.2024
Profil
Diantha Duvall is currently the Director at BioTheryX, Inc. since 2021 and the CFO, Treasurer & Chief Accounting Officer at Curis, Inc. since 2022.
Previously, she worked as the Executive Director at Merck & Co., Inc. from 2009 to 2015, the Global Commercial Controller at Biogen, Inc. from 2016 to 2017, the Chief Financial Officer at Genocea Biosciences, Inc. from 2019 to 2022, and the Chief Accounting Officer, VP & Controller at Bioverativ, Inc. from 2017 to 2019.
Ms. Duvall completed her undergraduate degree at Colby College and holds a graduate degree and an MBA from Northeastern University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CURIS, INC.
0,01% | 25.03.2024 | 644 ( 0,01% ) | 7 000 $ | 31.03.2024 |
Aktive Positionen von Diantha Duvall
Unternehmen | Position | Beginn |
---|---|---|
CURIS, INC. | Director of Finance/CFO | 05.08.2022 |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Director/Board Member | 09.08.2021 |
Ehemalige bekannte Positionen von Diantha Duvall
Unternehmen | Position | Ende |
---|---|---|
GENOCEA BIOSCIENCES, INC. | Director of Finance/CFO | 01.07.2022 |
BIOVERATIV INC | Comptroller/Controller/Auditor | 01.01.2019 |
BIOGEN INC. | Corporate Officer/Principal | 01.01.2017 |
MERCK & CO., INC. | Director/Board Member | 01.01.2015 |
Ausbildung von Diantha Duvall
Colby College | Undergraduate Degree |
Northeastern University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
BIOGEN INC. | Health Technology |
CURIS, INC. | Health Technology |
GENOCEA BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |
Bioverativ, Inc.
Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |